Chemomab Therapeutics Ltd Adr (CMMB)

Jan 09, 2025

LogicMark Inc (LGMK) Recovers 0.71% From Low: Are We There Yet? - Stocks Register

Jan 09, 2025

Nov 19, 2024

Oral Presentation at AASLD The Liver Meeting® 2024 Highlights Broad Clinical Activity of Chemomab’s CM-101 Across Multiple Biomarkers and Its Disease-Modifying Potential in Primary Sclerosing Cholangitis - GlobeNewswire Inc.

Nov 19, 2024

Nov 14, 2024

Chemomab Therapeutics Announces Third Quarter 2024 Financial Results and Provides Corporate Update - Investing.com

Nov 14, 2024

Oct 15, 2024

Chemomab reports progress in PSC treatment trial - Investing.com

Oct 15, 2024

Sep 20, 2024

Roth MKM Initiates Coverage of Chemomab Therapeutics LtdADR (CMMB) with Buy Recommendation - MSN

Sep 20, 2024

Sep 16, 2024

The Chemomab Therapeutics Ltd ADR (CMMB) had a good session last reading, didn’t it? - US Post News

Sep 16, 2024

Sep 13, 2024

Financial Health Check: Examining Chemomab Therapeutics Ltd ADR (CMMB)’s Key Ratios - The Dwinnex

Sep 13, 2024

Sep 09, 2024

Chemomab Therapeutics Ltd ADR (CMMB) Stock: Uncovering a 52-Week Range and Trading Volume - The InvestChronicle

Sep 09, 2024

Sep 09, 2024

Ratios Uncovered: Breaking Down Chemomab Therapeutics Ltd ADR (CMMB)’s Trailing Twelve Months Metrics - The Dwinnex

Sep 09, 2024

Sep 04, 2024

Is Chemomab Therapeutics Ltd ADR (CMMB) a good investment opportunity? - US Post News

Sep 04, 2024

Sep 03, 2024

CMMB stock touches 52-week high at $2.07 amid market fluctuations - Investing.com

Sep 03, 2024

Aug 27, 2024

Chemomab Therapeutics Ltd ADR (CMMB) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume - The InvestChronicle

Aug 27, 2024

Aug 27, 2024

Are Chemomab Therapeutics Ltd ADR (CMMB) shares a good deal now? - US Post News

Aug 27, 2024

Aug 26, 2024

CMMB stock touches 52-week high at $1.58 amid market fluctuations - Investing.com India

Aug 26, 2024

Aug 23, 2024

Chemomab Therapeutics Ltd ADR (CMMB) Stock: Uncovering 52-Week Market Trends - The InvestChronicle

Aug 23, 2024

Jul 26, 2024

Chemomab regains Nasdaq compliance with bid price rule - Investing.com

Jul 26, 2024

Jul 25, 2024

Chemomab secures $10 million in PIPE financing - Investing.com India

Jul 25, 2024

Jul 25, 2024

Chemomab Therapeutics Reveals Data From Mid-Stage Study For Liver Disease Candidate, Stock Plunges On Capital Raise - Benzinga

Jul 25, 2024

Jun 27, 2024

Chemomab Therapeutics (CMMB) Upgraded to Buy: Here's What You Should Know - Yahoo Finance

Jun 27, 2024

Mar 26, 2024

LGVN Stock Quote Price and Forecast - CNN

Mar 26, 2024

Feb 14, 2024

symbol__ Stock Quote Price and Forecast - CNN

Feb 14, 2024

Jan 13, 2023

Intercept (ICPT) Gains 12.4% in the Past Six Months: Here's Why - Zacks Investment Research

Jan 13, 2023

Dec 03, 2021

Chemomab Stock: Leading Anti-CCL24 mAb For Fibrotic Diseases (NASDAQ:CMMB) - Seeking Alpha

Dec 03, 2021

Jun 24, 2021

Chemomab And AGC Biologics Partner To Manufacture CM-101 For Phase II/III - Contract Pharma

Jun 24, 2021

Jun 17, 2021

What You Need To Know About Chemomab Therapeutics Ltd.'s (NASDAQ:CMMB) Investor Composition - Yahoo Finance

Jun 17, 2021

Mar 23, 2021

Chemomab Therapeutics (CMMB) Stock Price, News & Analysis - MarketBeat

Mar 23, 2021

Mar 18, 2021

Chemomab Therapeutics (NASDAQ:CMMB) Stock Quotes, Forecast and News Summary - Benzinga

Mar 18, 2021

Dec 16, 2020

The Daily Biotech Pulse: Novartis Gets Adcom Backing, Sio Gene Data, 2 IPOs, BioNTech Clinches China Vaccine Supply Deal - Yahoo Finance

Dec 16, 2020